US FDA Approves Drug To Treat HIV Infection In Newborns
GSK•FDA approves Tivicay PD for newborns
- US FDA: FDA approves drug to treat HIV infection in newborns.
- US FDA: Approves Tivicay PD tablets for oral suspension to treat HIV newborns from birth up to four weeks weighing at least 2 kg.
Further company coverage: GSK.L
